Search for: "Actavis Pharma"
Results 141 - 160
of 243
Sort by Relevance
|
Sort by Date
15 Jan 2013, 11:33 am
Companies Agree to Sell Rights to 18 Drugs to Satisfy FTCThe Federal Trade Commission will require Watson Pharmaceuticals, Inc. and Actavis Inc. to sell the rights and assets to 18 drugs to Sandoz International GmbH and Par Pharmaceuticals, Inc, and relinquish the manufacturing and marketing rights to three others, to settle charges that Watson’s proposed $5.9 billion acquisition of Actavis would otherwise be anticompetitive.... [read post]
30 Dec 2012, 9:30 pm
By Sherri Oslick -- About Court Report: Each week we will report briefly on recently filed biotech and pharma cases. [read post]
16 Nov 2012, 2:30 am
., Actavis Elizabeth LLC and Pliva Inc., manufacturers of the generic equivalent of Reglan, as well as Schwartz Pharma. [read post]
8 Apr 2012, 8:51 pm
Actavis Inc. et al. 1:12-cv-00323;... [read post]
7 Mar 2012, 2:33 am
Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
23 Feb 2012, 12:56 am
” The judge in Couick’s case ruled in favor of a dismissal against her claims against Wyeth and Schwarz Pharma, but would not do the same for PLIVA and Actavis. [read post]
26 Jan 2012, 6:57 am
Actavis appealed that verdict. [read post]
7 Dec 2011, 6:38 am
In November 2011, the FDA approved generic equivalents of the brand name product Kadian®, which is an extended-release morphine product manufactured by Actavis Elizabeth LLC. [read post]
2 Nov 2011, 2:00 am
French courts give conflicting answers in preliminary injunction proceedings: Actavis v Novartis (EPLAW) Vytorin (Ezetimibe and Simvastatin) – US: Schering files patent infringement complaint against Actavis in response to Para IV certification (Patent Docs) [read post]
28 Sep 2011, 1:56 am
Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
21 Sep 2011, 2:36 am
Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
16 Aug 2011, 11:35 pm
Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
14 Aug 2011, 9:59 pm
By Sherri Oslick -- About Court Report: Each week we will report briefly on recently filed biotech and pharma cases. [read post]
3 Aug 2011, 3:31 am
Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
1 Aug 2011, 8:19 am
The seven defendants, Actavis Elizabeth LLC, Sun Pharmaceuticals, Sandoz Inc., Mylan Pharmaceuticals, Apotex Inc., Aurobindo Pharma Ltd., and Teva Pharmaceuticals, had filed an Abbreviated New Drug Application (ANDA) seeking to utilize Lilly's patented formula and claiming invalidity of Lilly's patent, No. 5,658,590, Treatment of attention-deficit/hyperactivity disorder, which has been issued by the US Patent Office. [read post]
27 Jul 2011, 1:01 am
Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
13 Jul 2011, 3:04 am
Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
29 Jun 2011, 3:34 am
Mensing; Actavis, Inc. v. [read post]
15 Jun 2011, 4:56 am
General Big Pharma accepts differential pricing – FINALLY! [read post]
31 May 2011, 8:38 pm
Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
